White House Chief of Staff Susie Wiles, 68, announced she has been diagnosed with early-stage breast cancer and will continue her duties while undergoing treatment, according to President Donald Trump.

Diagnosis and Determination

Wiles revealed her diagnosis on Monday, just days after receiving the news the previous week. The longtime political strategist, who became the first woman to serve as White House chief of staff, made clear she has no plans to step back from her responsibilities during treatment. The announcement came during a Kennedy Center board meeting at the White House on March 16, where Wiles appeared alongside President Trump. Her decision to remain in one of the most demanding positions in American government demonstrates her commitment to public service and the administration’s agenda.

A Historic Role

Wiles took on the chief of staff position as the first woman ever appointed to the role, marking a significant milestone in White House history. Her responsibilities include managing the daily operations of the Executive Office of the President, coordinating between departments, and serving as a key advisor to Trump. Recent photographs show her participating in high-level meetings, including discussions with Israeli Prime Minister Benjamin Netanyahu in February 2025. The chief of staff role requires constant attention and demands that typically involve twelve to sixteen hour workdays, making her decision to continue working through treatment particularly notable.

Moving Forward

Early stage breast cancer diagnosis typically offers favorable treatment outcomes when detected promptly. Wiles has not disclosed specific details about her treatment plan or medical prognosis. Her professional background includes decades of political campaign management, having played crucial roles in multiple presidential and gubernatorial races. The White House has not announced any temporary adjustments to her duties or the appointment of additional staff to support operations during her treatment. Wiles’ approach reflects a growing trend of public figures maintaining their professional responsibilities while addressing serious health challenges, demonstrating that medical treatment and career dedication need not be mutually exclusive.